Refractory hemophagocytic lymphohistiocytosis secondary to polatuzumab vedotin plus rituximab and bendamustine

Ann Hematol. 2024 Mar;103(3):1017-1019. doi: 10.1007/s00277-023-05598-4. Epub 2023 Dec 29.

Kebing Lv¹, Fancong Kong^{1

2

3}, Min Yu^{1

2

3}, Yulan Zhou^{1

2

3}, Fei Li^{4

5

6}

¹ Center of Hematology, The First Affiliated Hospital of Nanchang University, No. 17 Yongwai StreetDonghu District, Nanchang, 330006, Jiangx, China.
² Jiangxi Clinical Research Center for Hematologic Disease, Nanchang, China.
³ Institute of Lymphoma and Myeloma, Nanchang University, Nanchang, China.
⁴ Center of Hematology, The First Affiliated Hospital of Nanchang University, No. 17 Yongwai StreetDonghu District, Nanchang, 330006, Jiangx, China. yx021021@sina.com.
⁵ Jiangxi Clinical Research Center for Hematologic Disease, Nanchang, China. yx021021@sina.com.
⁶ Institute of Lymphoma and Myeloma, Nanchang University, Nanchang, China. yx021021@sina.com.

No abstract available

Publication types